Martin Aringer Selected Research

Martin Aringer Research Topics

Disease

24	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2003
14	Lupus Nephritis 01/2022 - 10/2004
10	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2003
9	Rheumatoid Arthritis 09/2022 - 05/2005
8	Systemic Scleroderma (Systemic Sclerosis) 03/2022 - 08/2005
8	Arthritis (Polyarthritis) 01/2019 - 10/2004
7	Giant Cell Arteritis (Horton Disease) 05/2022 - 01/2017
7	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2022 - 11/2009
7	Rheumatic Diseases (Rheumatism) 01/2022 - 05/2008
6	Infections 11/2021 - 11/2004
5	Connective Tissue Diseases (Connective Tissue Disease) 03/2022 - 12/2007
4	Fatigue 09/2022 - 07/2012
4	Inflammation (Inflammations) 01/2022 - 11/2009
4	Proteinuria 01/2020 - 10/2004
4	Necrosis 01/2020 - 11/2011
3	Pain (Aches) 09/2022 - 01/2003
3	Virus Diseases (Viral Diseases) 01/2022 - 11/2004
3	Mixed Connective Tissue Disease (MCTD) 02/2012 - 08/2005
3	Gout 01/2011 - 04/2008
2	Renal Insufficiency (Renal Failure) 09/2022 - 01/2011
2	Dermatomyositis (Dermatopolymyositis) 01/2022 - 09/2014
2	Delirium 01/2021 - 12/2019
2	Alopecia (Baldness) 12/2020 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2020 - 03/2012
2	Fever (Fevers) 12/2019 - 01/2019
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2019 - 11/2016
2	Vasculitis (Vasculitides) 11/2012 - 05/2011
2	Pneumonia (Pneumonitis) 03/2012 - 11/2009
2	Hyperuricemia 08/2009 - 04/2008
2	Nephritis 07/2008 - 10/2004
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2022
1	Coronary Disease (Coronary Heart Disease) 09/2022
1	Disease Progression 02/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Panniculitis 01/2022
1	Diarrhea 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	COVID-19 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	malar rash 12/2020
1	Oral Ulcer (Mouth Ulcer) 12/2020

Drug/Important Bio-Agent (IBA)

13	AutoantibodiesIBA 01/2020 - 01/2003
12	GlucocorticoidsIBA 09/2022 - 11/2012
9	tocilizumab (atlizumab)FDA Link 09/2022 - 11/2011
9	AntibodiesIBA 01/2021 - 08/2005
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012 - 01/2003
8	Infliximab (Remicade)FDA Link 01/2020 - 10/2004
7	Rituximab (Mabthera)FDA Link 03/2022 - 05/2011
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2012
6	Antirheumatic Agents (DMARD)IBA 01/2020 - 11/2011
5	nintedanibIBA 03/2022 - 01/2021
5	Antinuclear AntibodiesIBA 01/2022 - 02/2012
5	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 10/2004
5	Tumor Necrosis Factor InhibitorsIBA 06/2017 - 01/2003
4	Prednisone (Sone)FDA LinkGeneric 01/2022 - 06/2013
4	Edetic Acid (EDTA)FDA Link 04/2021 - 11/2012
4	Biological ProductsIBA 01/2020 - 02/2015
4	CytokinesIBA 07/2012 - 01/2003
3	Janus Kinase InhibitorsIBA 01/2022 - 06/2017
3	baricitinibIBA 01/2022 - 06/2017
3	Leflunomide (Arava)FDA LinkGeneric 11/2021 - 06/2017
3	Etanercept (Enbrel)FDA Link 01/2020 - 05/2005
3	Phospholipids (Phosphatides)FDA LinkGeneric 12/2019 - 03/2012
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2019 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2022 - 11/2004
2	Calcineurin InhibitorsIBA 01/2022 - 01/2020
2	Antimalarials (Antimalarial Agents)IBA 11/2021 - 03/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
2	Antiphospholipid AntibodiesIBA 12/2020 - 01/2019
2	Abatacept (Orencia)FDA Link 01/2020 - 06/2017
2	sarilumabIBA 01/2020 - 06/2017
2	Adalimumab (Humira)FDA Link 01/2020 - 06/2017
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2002
2	Certolizumab Pegol FDA Link 01/2020 - 06/2017
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 06/2017
2	Janus KinasesIBA 01/2020 - 06/2017
2	tofacitinibIBA 01/2020 - 06/2017
2	Biosimilar PharmaceuticalsIBA 01/2020 - 06/2017
2	C-Reactive ProteinIBA 01/2020 - 07/2002
2	golimumab FDA Link 01/2020 - 06/2017
2	AntigensIBA 09/2019 - 05/2008
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2016 - 06/2013
2	belimumabIBA 02/2015 - 01/2015
2	EnzymesIBA 01/2015 - 06/2013
2	Azathioprine (Imuran)FDA LinkGeneric 06/2013 - 10/2004
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2012 - 05/2011
2	Uric Acid (Urate)IBA 08/2009 - 04/2008
2	CollagenIBA 08/2005 - 07/2002
1	ametantrone (HAQ)IBA 09/2022
1	Ligases (Synthetase)IBA 03/2022
1	voclosporinIBA 01/2022
1	anifrolumabIBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 11/2021

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2003
3	Immunomodulation 03/2022 - 01/2021
2	Plasma Exchange 01/2017 - 11/2004
1	Drug Therapy (Chemotherapy) 02/2022
1	Pain Management 10/2021
1	Stem Cell Transplantation 01/2021